Loading…
Hosted by Dr Andree Bates · 🇺🇸 US · EN · 216 episodes
Established thought leaders with verified media credentials.
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results.This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets to building results in a pharma company using AI and alert you to some fascinating new tools and applications to benefit you and your company.As the author of many peer-reviewed journals in pharma AI, and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI, futuretech, healthcare and pharma to help you to navigate through the, sometimes confusing, but magical world of AI powered tools to achieve real-world results. This podcast feat
Dr Andree Bates hosts AI For Pharma Growth, a technology show with 216 episodes published.
In this solo episode of AI For Pharma Growth, Dr Andree Bates explores why many pharma teams do not have an AI problem at all. They have a capability problem. Dr Andree starts with a simple question: when was your team l
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Nijat Ahmadov, CEO of Nucs AI, about molecular imaging as one of pharma’s most underused data assets. Nijat explains why PET, CT and other molecular im
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Jitesh Halai, founder and CEO of OneSC, about what the Qualified Person role should look like in a more proactive, digitally connected pharmaceutical s
In this solo episode of AI For Pharma Growth, Dr Andree Bates explains why “we’re doing AI” is not a credible board answer, and why activity, pilots and steering committees are not the same as strategy. Dr Andree breaks
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Bret Bostwick from Breyer Capital about the rare path from genetics, clinical medicine and drug development into venture capital, and what that perspec
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Smbat Rafayelyan, founder and CEO of Bioneex, about how AI is reshaping biopharma business development, deal scouting and asset evaluation. Business de
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Nuno Valério, Head of Innovation, R&D Quality at Merck Healthcare, about the part of AI governance most organisations rarely talk about: the operationa
In this solo episode of AI For Pharma Growth, Dr Andree Bates tackles one of the biggest reasons pharma AI strategies stall: they are not presented in the financial language a CFO can approve. Dr Andree argues that the i
For most of modern medicine, biological data has been built around population averages: what people like you might experience, rather than what you personally will. In this episode, Dr Andree Bates speaks with Ken Clark,
Most pharma companies are racing to apply AI across drug discovery, development and commercialisation, but many of those efforts will fail for one simple reason: the data underneath is not good enough. In this episode, D
On 7 May 2026, the EU reached a provisional agreement to push back the hardest deadlines in the EU AI Act. Many leadership teams heard one message: “we’ve got more time”. In this solo episode, Dr Andree Bates explains wh
In pharma, the biggest deals are increasingly won or lost before a formal process even begins. In this episode, Dr Andree Bates interviews Andrey Doronichev, co-founder and CEO of Bioptic, about the “intelligence gap” in
Real world evidence (RWE) could transform drug development and clinical care, but most organisations still struggle to turn messy clinical data into decisions they can trust. In this episode, Dr Andree Bates speaks with
Some of the most powerful breakthroughs happen when methods built for one discipline get turned on another. In this episode, Dr Andree Bates interviews Dr Irina Babina, CEO of Concr, on how computational techniques origi
Pharma doesn’t have an AI experimentation problem. It has an AI execution, scaling, and ROI justification problem. In this solo episode, Dr Andree Bates names one of the most expensive failure patterns in the industry: p
Cell therapies have huge potential, but cost, complexity, and centralised manufacturing have kept many of them confined to last-line use. In this episode, Dr Andree Bates speaks with Armon Sharei , Founder and CEO of Por
Clinical trial site selection is one of the biggest hidden bottlenecks in drug development, and it’s still often driven by legacy relationships, spreadsheets, and habit. In this episode, Dr Andree Bates interviews Simon
For many life sciences teams, the first wave of AI has looked like copilots: smart search, quick answers, and help on demand. Useful, but passive. In this episode, Dr Andree Bates is joined by Parth Khanna, CEO and co-fo
Many pharma and life science organisations have been investing in AI for years: pilots across commercial, medical, regulatory, and R&D, innovation labs, steering committees, vendor spend, and genuine effort from smart te
AI ethics has moved from theory to urgent necessity, especially as AI systems become embedded in healthcare, business decisions, and society at large. In this episode, Dr Andree Bates is joined by Dr Nadia Morozova, foun
Aaron Smith
Provincial Medical Executive Director for Northern Zone and Operational Co-Lead, Primary Care Clinics and Health Homes · Washington State Army National Guard
1 appearance on this show
Anthony Franco
founder of the world's first UX agency · First Strategy
1 appearance on this show
Nijat Ahmadov
Nucs AI
1 appearance on this show
Nuno Valério
Merck Healthcare
1 appearance on this show
Parth Khanna
ACTO
1 appearance on this show
Dr Nadia Morozova
Enriched Insights
1 appearance on this show
Quique Llaudet
Ephion Health
1 appearance on this show
Vitalay Fomin
Numenos
1 appearance on this show
Jocelyn Houle
Securiti.ai
1 appearance on this show
Dr Joseph Geraci
NetraMark
1 appearance on this show
Josh Taylor
TxtSquad
1 appearance on this show
Dr Morteza Zihayat
Heisenberg Network
1 appearance on this show
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
AI For Pharma Growth has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their technology audience.
AI For Pharma Growth is hosted by Dr Andree Bates. The show is categorised under technology and has published 216 episodes.
AI For Pharma Growth has published 216 episodes.
AI For Pharma Growth regularly covers technology. It sits in the technology category.
AI For Pharma Growth is accessible for guests with genuine technology expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
AI For Pharma Growth hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of AI For Pharma Growth average 32 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates AI For Pharma Growth's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.